MannKind Co. (NASDAQ:MNKD – Get Rating) CEO Michael Castagna sold 150,000 shares of the firm’s stock in a transaction that occurred on Wednesday, May 24th. The shares were sold at an average price of $4.69, for a total transaction of $703,500.00. Following the transaction, the chief executive officer now owns 2,331,735 shares in the company, […]
MannKind Co. (NASDAQ:MNKD – Get Rating) EVP David Thomson sold 95,576 shares of the stock in a transaction on Wednesday, May 24th. The stock was sold at an average price of $4.68, for a total value of $447,295.68. Following the completion of the transaction, the executive vice president now directly owns 735,263 shares of the […]
MannKind Co. (NASDAQ:MNKD – Get Rating) CFO Steven B. Binder sold 47,810 shares of the business’s stock in a transaction dated Wednesday, May 24th. The stock was sold at an average price of $4.67, for a total transaction of $223,272.70. Following the completion of the transaction, the chief financial officer now owns 838,324 shares of […]
Globeflex Capital L P purchased a new position in shares of MannKind Co. (NASDAQ:MNKD – Get Rating) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 111,234 shares of the biopharmaceutical company’s stock, valued at approximately $586,000. Other hedge […]
MannKind Co. (NASDAQ:MNKD – Get Rating) CEO Michael Castagna sold 150,000 shares of the business’s stock in a transaction on Wednesday, May 24th. The stock was sold at an average price of $4.69, for a total transaction of $703,500.00. Following the completion of the transaction, the chief executive officer now owns 2,331,735 shares in the […]